FDA PMA
FDA Class 3
30-Day Notice Accepted
🇺🇸 United States
Stent, Central Venous
PMA: P980033
·
Supplement: S067
·
Decision May 6, 2026
Classifications
1
FEI Numbers
0
Registration Numbers
0
Research PMA P980033 in seconds
The Research Assistant summarizes PMA approval history, supplements and related safety signals — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- Stent, Central Venous
- Trade Name
- WALLSTENT Venous Endoprosthesis with Unistep Plus Delivery System
- PMA Number
- P980033
- Supplement Number
- S067
- Device Class
- FDA Class 3
- Product Code
- QKJ
- Generic Name
- Stent, central venous
- Medical Specialty
- Unknown
- Advisory Committee
- Cardiovascular
- Decision
- 30-Day Notice Accepted
- Decision Code
- OK30
- Decision Date
- May 6, 2026
- Date Received
- April 8, 2026
- Supplement Type
- 30-Day Notice
- Supplement Reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Expedited Review
- N
Advisory Committee Statement
the extension of maximum transfer time between preconditioning cell to sterilization chamber during routine production for Ethylene Oxide(EtO) sterilization
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| QKJ | Stent, Central Venous | FDA class 3 | Unknown |